Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2008-12-2
pubmed:abstractText
Hyperinsulinism-hyperammonaemia syndrome (HHS) is a rare cause of congenital hyperinsulinism, due to missense mutations in the GLUD1 gene, resulting in glutamate dehydrogenase (GDH) overactivity. The aim of this study was to document the spectrum of neurological disturbances associated with HHS and to identify possible phenotype-genotype correlations. We retrospectively analyzed the neurological outcomes of 22 consecutive patients (12 males, 10 females) aged from 18 months to 40 years and diagnosed with HHS. We analyzed demographic and clinical features and neuroradiological, biochemical, and genetic findings. Fourteen patients had childhood-onset epilepsy. Learning disability was found in 17 patients. Two patients had pyramidal involvement and one had generalized dystonia. Seizures were observed in 11 of 19 patients with documented GLUD1 mutations, and nine of these 11 patients had a mutation in the guanosine triphosphate (GTP) binding site. Our data demonstrate that neurological disorders in HHS are more frequent than previously thought and might suggest that mutations in the GTP binding site of GDH could be associated with more frequent epilepsy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1469-8749
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
945-9
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed-meshheading:19046187-Adolescent, pubmed-meshheading:19046187-Adult, pubmed-meshheading:19046187-Alleles, pubmed-meshheading:19046187-Brain, pubmed-meshheading:19046187-Brain Damage, Chronic, pubmed-meshheading:19046187-Child, pubmed-meshheading:19046187-Child, Preschool, pubmed-meshheading:19046187-DNA Mutational Analysis, pubmed-meshheading:19046187-Electroencephalography, pubmed-meshheading:19046187-Enzyme Activation, pubmed-meshheading:19046187-Epilepsies, Myoclonic, pubmed-meshheading:19046187-Epilepsy, Absence, pubmed-meshheading:19046187-Epilepsy, Generalized, pubmed-meshheading:19046187-Epilepsy, Tonic-Clonic, pubmed-meshheading:19046187-Female, pubmed-meshheading:19046187-Genotype, pubmed-meshheading:19046187-Glutamate Dehydrogenase, pubmed-meshheading:19046187-Guanosine Triphosphate, pubmed-meshheading:19046187-Humans, pubmed-meshheading:19046187-Hyperammonemia, pubmed-meshheading:19046187-Hyperinsulinism, pubmed-meshheading:19046187-Hypoglycemia, pubmed-meshheading:19046187-Infant, pubmed-meshheading:19046187-Liver, pubmed-meshheading:19046187-Magnetic Resonance Imaging, pubmed-meshheading:19046187-Male, pubmed-meshheading:19046187-Mutation, Missense, pubmed-meshheading:19046187-Neurologic Examination, pubmed-meshheading:19046187-Pancreas, pubmed-meshheading:19046187-Phenotype, pubmed-meshheading:19046187-Retrospective Studies, pubmed-meshheading:19046187-Young Adult
pubmed:year
2008
pubmed:articleTitle
Neurological aspects of hyperinsulinism-hyperammonaemia syndrome.
pubmed:affiliation
Department of Paediatric Neurology and Metabolic Diseases, Necker Children's Hospital, Paris V University, Paris, France. nadia.bahi-buisson@nck.aphp.fr
pubmed:publicationType
Journal Article